Cost-effectiveness analysis of the introduction of the pneumococcal conjugate vaccine (PCV-13) in the Egyptian national immunization program, 2013.

Sibak, M; Moussa, I; El-Tantawy, N; Badr, S; Chaudhri, I; Allam, E; Baxter, L; Abo Freikha, S; Hoestlandt, C; Lara, C; +2 more... Hajjeh, R; Munier, A; (2014) Cost-effectiveness analysis of the introduction of the pneumococcal conjugate vaccine (PCV-13) in the Egyptian national immunization program, 2013. Vaccine, 33 Sup. A182-91. ISSN 0264-410X DOI: https://doi.org/10.1016/j.vaccine.2014.12.044

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/j.vaccine.2014.12.044

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar